Glipizide Tablet
Product Images NDC 51655-180

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 180 26 Rev A 06 20)

Label for Glipizide Tablets USP 5 mg, oral tablets available in a bottle of 90 tablets. The label includes storage instructions, dosage note to see package insert, and is marked Rx only. Manufactured and repackaged by Northwind Pharmaceuticals, under NDC 51655-180-26.*

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Chemical structure diagram of Glipizide, showing its molecular components including a methyl-substituted pyridine ring, phenyl group, sulfonamide, and a cyclohexyl group attached through an amide linkage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.